Filing Details
- Accession Number:
- 0001562180-24-006014
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-05 18:39:05
- Reporting Period:
- 2024-08-01
- Accepted Time:
- 2024-08-05 18:39:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1590877 | Regenxbio Inc. | RGNX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1346164 | Curran Simpson | C/O Regenxbio Inc. 9804 Medical Center Drive Rockville MD 20850 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-08-01 | 100 | $15.00 | 170,037 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan as adopted on March 15, 2024.
Billionaire Hedge Funds
